NCT02550249View on ClinicalTrials.gov

Neoadjuvant Nivolumab in Glioblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Glioblastoma Multiforme
Interventions
DRUG

Nivolumab

Intravenous administration of nivolumab

Trial Locations (1)

31008

Clinica Universidad de Navarra, Pamplona

All Listed Sponsors
lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT02550249 - Neoadjuvant Nivolumab in Glioblastoma | Biotech Hunter | Biotech Hunter